Novel 5-fluorouracil derivative
AssigneeDelta-Fly Pharma, Inc.
InventorsMasakazu FUKUSHIMA, Shozo Yamada, Ryo Oyama
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel antimetabolic anticancer agent that has an excellent balance between antitumor effect and toxicity. Specifically, the present invention provides a medicament containing, as an active ingredient, a 5-fluorouracil derivative represented by Formula (I) or a salt thereof: wherein R1 represents a hydrogen atom or a protecting group of a hydroxy group, R2 represents a lower alkoxy-lower alkyl group or a tetrahydrofuranyl group, X represents a carbon atom or a nitrogen atom, and Y represents a halogen atom or a cyano group.
Claims11
A 5-fluorouracil derivative represented by Formula (I) below or a salt thereof:
- wherein R1 represents a hydrogen atom or a protecting group of a hydroxy group, R2 represents a lower alkoxy-lower alkyl group or a tetrahydrofuranyl group, X represents a carbon atom or a nitrogen atom, and Y represents a halogen atom or a cyano group.
Dependencies are inferred from the claim text.